The Abu Dhabi Brain Conference, held from 12 to 14 September at the InterContinental Abu Dhabi, brought together neurologists, clinicians, researchers, and healthcare leaders to discuss advances in the diagnosis and management of neurological and neurodegenerative disorders.
As a Gold Sponsor and Exhibitor, the National Reference Laboratory (NRL) showcased its leadership in advanced neuro-biochemical diagnostics, highlighting biomarker panels that support early detection and clinical decision-making for conditions such as Alzheimer’s disease and related dementias.
Through scientific exchange and professional engagement, NRL reinforced its commitment to elevating diagnostic excellence and supporting improved patient outcomes across the region.
